Literature DB >> 32336614

Fatal association of fulminant myocarditis and rhabdomyolysis after immune checkpoint blockade.

Raluca Tomoaia1, Ruxandra Ș Beyer2, Dana Pop3, Ioan A Minciună3, Alexandra Dădârlat-Pop4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32336614     DOI： 10.1016/j.ejca.2020.03.003

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  3 in total

1.  Immune Checkpoint Inhibitor-Induced Myocarditis with Myositis/Myasthenia Gravis Overlap Syndrome: A Systematic Review of Cases.

Authors:  Ranjan Pathak; Anjan Katel; Erminia Massarelli; Victoria M Villaflor; Virginia Sun; Ravi Salgia
Journal:  Oncologist       Date:  2021-08-25

2.  Rhabdomyolysis following single administration of pembrolizumab: Is severe immune-reaction a marker for durable treatment response?

Authors:  Varun Khetan; Erin A Blake; Marcia A Ciccone; Koji Matsuo
Journal:  Gynecol Oncol Rep       Date:  2021-01-11

3.  NLRP3 as Putative Marker of Ipilimumab-Induced Cardiotoxicity in the Presence of Hyperglycemia in Estrogen-Responsive and Triple-Negative Breast Cancer Cells.

Authors:  Vincenzo Quagliariello; Michelino De Laurentiis; Stefania Cocco; Giuseppina Rea; Annamaria Bonelli; Antonietta Caronna; Maria Cristina Lombari; Gabriele Conforti; Massimiliano Berretta; Gerardo Botti; Nicola Maurea
Journal:  Int J Mol Sci       Date:  2020-10-21       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.